ID   NO66_HUMAN              Reviewed;         641 AA.
AC   Q9H6W3; B4DT02;
DT   12-DEC-2006, integrated into UniProtKB/Swiss-Prot.
DT   19-JAN-2010, sequence version 2.
DT   07-JAN-2015, entry version 104.
DE   RecName: Full=Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66;
DE            EC=1.14.11.-;
DE            EC=1.14.11.27;
DE   AltName: Full=60S ribosomal protein L8 histidine hydroxylase;
DE   AltName: Full=Histone lysine demethylase NO66;
DE   AltName: Full=Myc-associated protein with JmjC domain;
DE   AltName: Full=Nucleolar protein 66;
DE            Short=hsNO66;
DE   AltName: Full=Ribosomal oxygenase NO66;
DE            Short=ROX;
GN   Name=NO66; Synonyms=C14orf169, MAPJD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND VARIANTS ARG-17 AND ALA-364.
RX   PubMed=14742713; DOI=10.1091/mbc.E03-08-0623;
RA   Eilbracht J., Reichenzeller M., Hergt M., Schnoelzer M., Heid H.,
RA   Stoehr M., Franke W.W., Schmidt-Zachmann M.S.;
RT   "NO66, a highly conserved dual location protein in the nucleolus and
RT   in a special type of synchronously replicating chromatin.";
RL   Mol. Biol. Cell 15:1816-1832(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS ARG-17 AND ALA-364.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   ARG-17 AND ALA-364.
RC   TISSUE=Lymph, and Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, INTERACTION WITH MYC, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=17308053; DOI=10.1158/1535-7163.MCT-06-0659;
RA   Suzuki C., Takahashi K., Hayama S., Ishikawa N., Kato T., Ito T.,
RA   Tsuchiya E., Nakamura Y., Daigo Y.;
RT   "Identification of Myc-associated protein with JmjC domain as a novel
RT   therapeutic target oncogene for lung cancer.";
RL   Mol. Cancer Ther. 6:542-551(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   INTERACTION WITH PHF19.
RX   PubMed=23160351; DOI=10.1038/nsmb.2449;
RA   Brien G.L., Gambero G., O'Connell D.J., Jerman E., Turner S.A.,
RA   Egan C.M., Dunne E.J., Jurgens M.C., Wynne K., Piao L., Lohan A.J.,
RA   Ferguson N., Shi X., Sinha K.M., Loftus B.J., Cagney G., Bracken A.P.;
RT   "Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66
RT   to embryonic stem cell genes during differentiation.";
RL   Nat. Struct. Mol. Biol. 19:1273-1281(2012).
RN   [9]
RP   FUNCTION AS RPL8 HYDROXYLASE, AND CATALYTIC ACTIVITY.
RX   PubMed=23103944; DOI=10.1038/nchembio.1093;
RA   Ge W., Wolf A., Feng T., Ho C.H., Sekirnik R., Zayer A., Granatino N.,
RA   Cockman M.E., Loenarz C., Loik N.D., Hardy A.P., Claridge T.D.,
RA   Hamed R.B., Chowdhury R., Gong L., Robinson C.V., Trudgian D.C.,
RA   Jiang M., Mackeen M.M., McCullagh J.S., Gordiyenko Y., Thalhammer A.,
RA   Yamamoto A., Yang M., Liu-Yi P., Zhang Z., Schmidt-Zachmann M.,
RA   Kessler B.M., Ratcliffe P.J., Preston G.M., Coleman M.L.,
RA   Schofield C.J.;
RT   "Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and
RT   humans.";
RL   Nat. Chem. Biol. 8:960-962(2012).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Oxygenase that can act as both a histone lysine
CC       demethylase and a ribosomal histidine hydroxylase. Specifically
CC       demethylates 'Lys-4' (H3K4me) and 'Lys-36' (H3K36me) of histone
CC       H3, thereby playing a central role in histone code. Preferentially
CC       demethylates trimethylated H3 'Lys-4' (H3K4me3) and monomethylated
CC       H3 'Lys-4' (H3K4me1) residues, while it has weaker activity for
CC       dimethylated H3 'Lys-36' (H3K36me2). Also catalyzes the
CC       hydroxylation of 60S ribosomal protein L8 on 'His-216'. Acts as a
CC       regulator of osteoblast differentiation via its interaction with
CC       SP7/OSX by demethylating H3K4me and H3K36me, thereby inhibiting
CC       SP7/OSX-mediated promoter activation (By similarity). May also
CC       play a role in ribosome biogenesis and in the replication or
CC       remodeling of certain heterochromatic region. Participates in MYC-
CC       induced transcriptional activation. {ECO:0000250,
CC       ECO:0000269|PubMed:14742713, ECO:0000269|PubMed:17308053,
CC       ECO:0000269|PubMed:23103944}.
CC   -!- CATALYTIC ACTIVITY: Protein N(6),N(6)-dimethyl-L-lysine + 2-
CC       oxoglutarate + O(2) = protein N(6)-methyl-L-lysine + succinate +
CC       formaldehyde + CO(2). {ECO:0000269|PubMed:23103944}.
CC   -!- CATALYTIC ACTIVITY: Protein N(6)-methyl-L-lysine + 2-oxoglutarate
CC       + O(2) = protein L-lysine + succinate + formaldehyde + CO(2).
CC       {ECO:0000269|PubMed:23103944}.
CC   -!- CATALYTIC ACTIVITY: L-histidine-[60S ribosomal protein L8] + 2-
CC       oxoglutarate + O(2) = (3S)-3-hydroxy-L-histidine-[60S ribosomal
CC       protein L8] + succinate + CO(2). {ECO:0000269|PubMed:23103944}.
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000250};
CC       Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Interacts with SP7/OSX; the interaction is direct (By
CC       similarity). Interacts with MYC. Interacts with PHF19; leading to
CC       its recruitment to H3K36me3 sites. {ECO:0000250,
CC       ECO:0000269|PubMed:17308053, ECO:0000269|PubMed:23160351}.
CC   -!- INTERACTION:
CC       Q8VI67:Sp7 (xeno); NbExp=6; IntAct=EBI-2513645, EBI-7608836;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus. Nucleus, nucleoplasm.
CC       Note=Granular part of nucleoli. Nucleoplasm, nucleoplasmic foci,
CC       some of them associated with nucleoli.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H6W3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H6W3-2; Sequence=VSP_038663;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Overexpressed in lung
CC       carcinomas. {ECO:0000269|PubMed:14742713,
CC       ECO:0000269|PubMed:17308053}.
CC   -!- SIMILARITY: Belongs to the MINA53/NO66 family. NO66 subfamily.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 JmjC domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00538}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY390535; AAR27292.1; -; mRNA.
DR   EMBL; AK025455; BAB15138.1; -; mRNA.
DR   EMBL; AK299994; BAG61814.1; -; mRNA.
DR   EMBL; AC005280; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC011350; AAH11350.1; -; mRNA.
DR   EMBL; BC071954; AAH71954.1; -; mRNA.
DR   CCDS; CCDS73660.1; -. [Q9H6W3-1]
DR   RefSeq; NP_078920.2; NM_024644.4. [Q9H6W3-1]
DR   UniGene; Hs.509916; -.
DR   PDB; 4CCJ; X-ray; 2.15 A; A/B/C/D=183-641.
DR   PDB; 4CCK; X-ray; 2.15 A; A/B/C/D=183-641.
DR   PDB; 4CCM; X-ray; 2.51 A; A/B=183-641.
DR   PDB; 4CCN; X-ray; 2.23 A; A/B=183-641.
DR   PDB; 4CCO; X-ray; 2.30 A; A/B=183-641.
DR   PDB; 4DIQ; X-ray; 2.40 A; A/B=167-641.
DR   PDB; 4E4H; X-ray; 2.28 A; A/B/C/D=183-641.
DR   PDBsum; 4CCJ; -.
DR   PDBsum; 4CCK; -.
DR   PDBsum; 4CCM; -.
DR   PDBsum; 4CCN; -.
DR   PDBsum; 4CCO; -.
DR   PDBsum; 4DIQ; -.
DR   PDBsum; 4E4H; -.
DR   ProteinModelPortal; Q9H6W3; -.
DR   SMR; Q9H6W3; 183-639.
DR   BioGrid; 122818; 4.
DR   DIP; DIP-53768N; -.
DR   IntAct; Q9H6W3; 3.
DR   MINT; MINT-5009834; -.
DR   PhosphoSite; Q9H6W3; -.
DR   DMDM; 284018103; -.
DR   MaxQB; Q9H6W3; -.
DR   PeptideAtlas; Q9H6W3; -.
DR   PRIDE; Q9H6W3; -.
DR   Ensembl; ENST00000304061; ENSP00000477507; ENSG00000170468. [Q9H6W3-1]
DR   GeneID; 79697; -.
DR   KEGG; hsa:79697; -.
DR   UCSC; uc001xok.1; human. [Q9H6W3-1]
DR   CTD; 79697; -.
DR   GeneCards; GC14P073958; -.
DR   H-InvDB; HIX0011794; -.
DR   HGNC; HGNC:20968; C14orf169.
DR   MIM; 611919; gene.
DR   neXtProt; NX_Q9H6W3; -.
DR   PharmGKB; PA134919088; -.
DR   GeneTree; ENSGT00390000000083; -.
DR   HOVERGEN; HBG060021; -.
DR   InParanoid; Q9H6W3; -.
DR   KO; K16914; -.
DR   PhylomeDB; Q9H6W3; -.
DR   GenomeRNAi; 79697; -.
DR   NextBio; 68992; -.
DR   PRO; PR:Q9H6W3; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   CleanEx; HS_C14orf169; -.
DR   Genevestigator; Q9H6W3; -.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0051864; F:histone demethylase activity (H3-K36 specific); ISS:UniProtKB.
DR   GO; GO:0032453; F:histone demethylase activity (H3-K4 specific); ISS:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; ISS:UniProtKB.
DR   GO; GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; ISS:UniProtKB.
DR   GO; GO:0070544; P:histone H3-K36 demethylation; ISS:UniProtKB.
DR   GO; GO:0034720; P:histone H3-K4 demethylation; ISS:UniProtKB.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR003347; JmjC_dom.
DR   Pfam; PF08007; Cupin_4; 1.
DR   SMART; SM00558; JmjC; 1.
DR   PROSITE; PS51184; JMJC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromatin regulator;
KW   Complete proteome; Dioxygenase; Iron; Metal-binding; Nucleus;
KW   Oxidoreductase; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repressor; Transcription; Transcription regulation.
FT   CHAIN         1    641       Bifunctional lysine-specific demethylase
FT                                and histidyl-hydroxylase NO66.
FT                                /FTId=PRO_0000264613.
FT   DOMAIN      294    439       JmjC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00538}.
FT   METAL       340    340       Iron; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00538}.
FT   METAL       342    342       Iron; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00538}.
FT   METAL       405    405       Iron; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00538}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000269|PubMed:22814378}.
FT   MOD_RES     109    109       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:19690332}.
FT   VAR_SEQ       1    212       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038663.
FT   VARIANT      17     17       K -> R (in dbSNP:rs10144469).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:14742713,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_062422.
FT   VARIANT     218    218       F -> S (in dbSNP:rs758109).
FT                                /FTId=VAR_057819.
FT   VARIANT     239    239       Q -> H (in dbSNP:rs34970526).
FT                                /FTId=VAR_060191.
FT   VARIANT     364    364       V -> A (in dbSNP:rs3813563).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:14742713,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_062423.
FT   CONFLICT    392    392       E -> G (in Ref. 2; BAG61814).
FT                                {ECO:0000305}.
FT   HELIX       184    193       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       198    210       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       215    221       {ECO:0000244|PDB:4CCJ}.
FT   TURN        222    225       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      228    230       {ECO:0000244|PDB:4CCJ}.
FT   TURN        235    240       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       244    253       {ECO:0000244|PDB:4CCJ}.
FT   TURN        259    261       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      262    268       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      271    274       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      278    280       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       283    291       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      295    299       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       301    303       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       306    319       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      324    330       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      332    334       {ECO:0000244|PDB:4CCN}.
FT   STRAND      343    353       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      355    359       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       365    367       {ECO:0000244|PDB:4CCJ}.
FT   TURN        379    381       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      386    391       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      396    399       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      405    408       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      415    422       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       428    446       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       448    451       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       458    460       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       464    466       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       472    487       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       488    491       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       494    508       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       516    520       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       523    525       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      529    531       {ECO:0000244|PDB:4E4H}.
FT   STRAND      535    537       {ECO:0000244|PDB:4CCN}.
FT   STRAND      547    561       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      564    570       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      583    587       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       589    591       {ECO:0000244|PDB:4CCJ}.
FT   HELIX       592    600       {ECO:0000244|PDB:4CCJ}.
FT   TURN        601    603       {ECO:0000244|PDB:4DIQ}.
FT   HELIX       608    610       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      612    615       {ECO:0000244|PDB:4CCM}.
FT   HELIX       616    628       {ECO:0000244|PDB:4CCJ}.
FT   STRAND      632    636       {ECO:0000244|PDB:4CCJ}.
SQ   SEQUENCE   641 AA;  71086 MW;  E66A4342B1D1BFF2 CRC64;
     MDGLQASAGP LRRGRPKRRR KPQPHSGSVL ALPLRSRKIR KQLRSVVSRM AALRTQTLPS
     ENSEESRVES TADDLGDALP GGAAVAAVPD AARREPYGHL GPAELLEASP AARSLQTPSA
     RLVPASAPPA RLVEVPAAPV RVVETSALLC TAQHLAAVQS SGAPATASGP QVDNTGGEPA
     WDSPLRRVLA ELNRIPSSRR RAARLFEWLI APMPPDHFYR RLWEREAVLV RRQDHTYYQG
     LFSTADLDSM LRNEEVQFGQ HLDAARYING RRETLNPPGR ALPAAAWSLY QAGCSLRLLC
     PQAFSTTVWQ FLAVLQEQFG SMAGSNVYLT PPNSQGFAPH YDDIEAFVLQ LEGRKLWRVY
     RPRVPTEELA LTSSPNFSQD DLGEPVLQTV LEPGDLLYFP RGFIHQAECQ DGVHSLHLTL
     STYQRNTWGD FLEAILPLAV QAAMEENVEF RRGLPRDFMD YMGAQHSDSK DPRRTAFMEK
     VRVLVARLGH FAPVDAVADQ RAKDFIHDSL PPVLTDRERA LSVYGLPIRW EAGEPVNVGA
     QLTTETEVHM LQDGIARLVG EGGHLFLYYT VENSRVYHLE EPKCLEIYPQ QADAMELLLG
     SYPEFVRVGD LPCDSVEDQL SLATTLYDKG LLLTKMPLAL N
//
